You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
山東新華製藥股份(00719.HK)完成註銷部分A股股票期權
格隆匯 01-21 16:34

格隆匯 1 月 21日丨山東新華製藥股份(00719.HK)公吿,山東新華製藥股份有限公司(以下簡稱“公司”)於2020年12月28日召開了第十屆董事會2020年第一次臨時會議、第十屆監事會2020年第一次臨時會議,審議通過了《關於調整股票期權激勵計劃行權價格、激勵對象名單及授予期權數量並註銷部分期權的議案》,由於公司股票期權激勵計劃授予激勵對象中1人因個人原因離職,公司對其已獲授未行權的5.000萬份股票期權予以註銷。 

公司本次註銷1名激勵對象持有的尚未行權的股票期權共計5.000萬份,佔註銷前公司總股本的0.008%。本次股票期權註銷事宜,符合法律、行政法規、部門規章、規範性文件、《山東新華製藥股份有限公司章程》及《山東新華製藥股份有限公司2018年A股股票期權激勵計劃(草案)》等的相關規定。

公司已在中國證券登記結算有限責任公司深圳分公司辦理完成上述5.000萬份已獲授的股票期權註銷事宜,本次註銷不影響公司股本,公司股本結構未發生變化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account